switching from compounded semaglutide to tirzepatide Tirzepatide: A Provider's Guide switching from semaglutide to tirzepatide
Description
503 -
True insight requires both the what and the why
A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year
Drug exposure is largely independent of injection site, as well as age, race and ethnicity
